Coleman also Reaffirms Support for IVF Treatments
FRANKFORT, KY – Attorney General Russell Coleman announced he joined 21 fellow attorneys general in a brief encouraging the U.S. Supreme Court to critically review the politics-driven process used by the U.S. Food and Drug Administration (FDA) during both the Obama and Biden Administrations to loosen restrictions on the abortion drug, mifepristone.
When the drug was first approved by the FDA in 2000, the agency required it be dispensed under a certified physician’s supervision in clinics, medical offices or hospitals. In 2021, the FDA ignored its own previous scientific recommendations and dropped the in-person-dispensing requirements. In effect, the FDA overrode the will of the people’s representatives in Congress and the States in an attempt to impose a nationwide elective-abortion regime.
“The FDA is tasked with protecting Americans’ health and safety, not advancing an abortion-on-demand agenda,” said General Coleman. “From mask mandates to lockdowns, we’ve watched federal agencies follow the politics not the science.”
“It’s time to restore sanity. Rather than forcing an out-of-touch ideology on us, the government should focus on issues that matter, like safeguarding access to IVF – which is an incredible blessing for so many seeking to become parents,” General Coleman continued.
General Coleman joined the amicus brief led by Mississippi Attorney General Lynn Fitch along with attorneys general from Alabama, Alaska, Arkansas, Florida, Georgia, Indiana, Iowa, Louisiana, Mississippi, Montana, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, West Virginia, and Wyoming.
Read the full brief.
###
